STIM - Neuronetics Inc. Analyst Forecast Prices

Corporate company logo of NeuroStar (STIM)

Neuronetics, Inc. is scaling the deployment of NeuroStar systems through a strategic alliance with psychiatric centers, as confirmed by this price chart. The current indicator stands at 6.01. The business model is recession-resistant due to stable demand for depression therapy. Meanwhile, financial success relies on the expansion of insurance reimbursements and rigorous monitoring of commercial department efficiency.

Neuronetics (STIM): Price Target Chart from 07/04/2022 to 11/11/2026
Core merchandise of Neuronetics Inc.

This indicator reflects the trend of fair value revisions for the asset by leading investment banks, eliminating time lags between financial reporting and the adjustment of market expectations. By analyzing the weighted average price target for the stock on GURU.Markets, an investor assesses the impact of magnetic stimulation system sales on the capitalization of Neuronetics, Inc. (STIM), allowing for the rapid verification of the business's fundamental stability within the mental health therapy sector.

Competing companies

Analyst Median Target bostonscientific.com|Edwards Lifesciences Corporation - Consensus Target|Analyst Forecast Prices RMD (ResMed Inc)|OmniPod - Analyst Consensus Forecast|Analyst Median Target Zimmer Biomet Corp ZBH|The Cooper Companies (COO) - Price Target Chart|Consensus Target aligntech.com|Price Target Chart Globus Medical|TransMedics (TMDX) - Analyst Median Target|Price Target Chart ATEC Spine (ATEC)|AORT: Forecast Levels Chart|Analyst Consensus Forecast ENOV (Enovis Corporation)|integralife.com (IART) - Average Forecast Price|Establishment Labs Holdings Inc. - Analyst Consensus Forecast|Beta Bionics, Inc. (BBNX) - Consensus Target|IRMD: Analyst Consensus Forecast|EMBC - Analyst Median Target|TNDM (Tandem Diabetes Care) - Analyst Consensus Forecast|Analyst Consensus Forecast axogeninc.com|Price Target Chart SI-BONE (SIBN)|Price Target Chart OFIX (Orthofix Medical)|Analyst Consensus Forecast BVS (Bioventus Corp)|Analyst Median Target OrthoPediatrics Corp (KIDS)|TMCI: Consensus Target|Forecast Levels Chart SRTA|CARL: Analyst Consensus Forecast|Average Forecast Price RxSight Inc (RXST)|CLPT (ClearPoint Neuro Inc.) - Analyst Consensus Forecast|Broker Consensus Forecast STXS (Stereotaxis Corporation)|Consensus Target SGHT (Sight Sciences, Inc.)|OBIO (Orchestra BioMed Inc.) - Fair Value Consensus|Price Target Chart Anika Therapeutics, Inc. ANIK|NSPR - Consensus Target|Jin Medical International Ltd - Analyst Consensus Forecast|Average Forecast Price Vivani Medical, Inc.|XTNT: Analyst Consensus Forecast|Broker Consensus Forecast NMTC|MODD (Modular Medical Inc) - Analyst Consensus Forecast|Myomo Inc. (MYO) - Analyst Median Target|Analyst Consensus Forecast COCH|Consensus Target Vivos Therapeutics Inc VVOS|Analyst Consensus Forecast NVNO (enVVeno Medical)|Analyst Consensus Forecast Sintx Technologies Inc SINT|TNON - Price Target Chart|LFWD: Price Target Chart|AMIX (autonomix.com) - Consensus Target|INVO Fertility Corp - Fair Value Consensus|BBLG (Bone Biologics) - Analyst Consensus Forecast|Average Forecast Price axonics.com AXNX|Price Target Chart BIOLASE (BIOL)|dynatronics.com (DYNT) - Analyst Target Range|Paragon 28 - Consensus Target|Analyst Consensus Forecast INVO Bioscience Inc. INVO